Screening Evaluation of the Evolution of New Heart Failure (SCREEN-HF)

NCT00400257 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3500

Last updated 2016-06-01

No results posted yet for this study

Summary

The investigators are hoping to identify early heart failure in patients who do not have symptoms as yet and at the same time assess the usefulness of Brain natriuretic peptide (BNP) in doing this.

Conditions

Interventions

BEHAVIORAL

Early detection of heart failure

Early detection of heart failure

Sponsors & Collaborators

  • HBA

    collaborator UNKNOWN
  • Ingrid Hopper

    lead OTHER

Principal Investigators

  • Henry Krum, Professor · Monash University / Alfred Hospital

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2010-01-31
Completion
2015-12-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00400257 on ClinicalTrials.gov